Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001396677-15-000008
Filing Date
2015-01-30
Accepted
2015-01-30 19:11:49
Documents
1
Period of Report
2015-01-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3/A  
1 PRIMARY DOCUMENT primary_doc.xml 3/A 2247
  Complete submission text file 0001396677-15-000008.txt   3693
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Issuer) CIK: 0001050007 (see all company filings)

EIN.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address C/O NUTRACEUTICAL INTERNATIONAL CORP 1400 KEARNS BOULEVARD 2ND FL. PARK CITY UT 84060
Business Address
Vance Matthew A. (Reporting) CIK: 0001631979 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-23731 | Film No.: 15564605